HERON THERAPEUTICS, INC. /DE/ Additional Paid in Capital
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Additional Paid in Capital of $1.96 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-10
- 2026-06-30: Additional Paid in Capital $1.96B.
- 2026-03-31: Additional Paid in Capital $1.95B.
- 2025-12-31: Additional Paid in Capital $1.95B.
- 2025-09-30: Additional Paid in Capital $1.94B.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $1.96B 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.95B 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $1.95B 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.94B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.89B 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.89B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.88B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.88B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.88B 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.87B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.87B 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.87B 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.83B 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.82B 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.81B 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.80B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.71B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.70B 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.69B 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.68B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.67B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.64B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.63B 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.61B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.59B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.58B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.57B 10-K · filed 2021-02-24 | |
| 2019-09-30 | $1.39B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.38B 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.35B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.33B 10-K · filed 2020-03-02 | |
| 2018-09-30 | $1.32B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.30B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $925.75M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $913.96M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $760.47M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $747.64M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $737.95M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $564.34M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $555.51M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $546.95M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $538.59M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $530.62M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $522.93M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $518.42M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $383.51M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $378.01M 10-K · filed 2016-02-19 | |
| 2014-09-30 | $375.33M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $372.98M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $311.58M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $307.58M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $242.59M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $237.39M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $234.87M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $235.25M 10-K · filed 2014-03-07 | $232.38M 10-K · filed 2013-03-01 |
| 2012-09-30 | $230.34M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $178.84M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $174.79M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $173.99M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $173.17M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $151.19M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $149.34M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |